Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anette Duensing

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Cancers|December 23, 2023
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell CarcinomaViktoria Schütz, Huan Lin, Adam Kaczorowski, et al.
Journal of Bone Oncology|June 7, 2021
Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomasKaren Schoedel, Virginia Miller, David Osei-Hwedieh, et al.
Oncogene|September 21, 2004
Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomaliesStefan Duensing, Anette Duensing, David C Lee, et al.
Frontiers in Oncology|May 27, 2022
Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and OpportunitiesLaura Pohl, Jana Friedhoff, Christina Jurcic, et al.
Frontiers in Oncology|May 12, 2025
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept studyJakob Wieke, Christina Jurcic, Adam Kaczorowski, et al.
Oncogene|March 10, 2004
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)Anette Duensing, Fabiola Medeiros, Bryna McConarty, et al.
The American Journal of Surgical Pathology|June 30, 2004
KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implicationsFabiola Medeiros, Christopher L Corless, Anette Duensing, et al.
Scientific Reports|August 31, 2024
Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BADAnn-Kathrin Huber, Adam Kaczorowski, Felix Schneider, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active SurveillanceViktoria Schütz, Maresa Rothermel, Adam Kaczorowski, et al.
Molecular Oncology|December 1, 2010
Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cellsDavid Reynoso, Laura K Nolden, Dan Yang, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Cancers|December 23, 2023
Long-Term Survival of Patients with Stage T1N0M1 Renal Cell CarcinomaViktoria Schütz, Huan Lin, Adam Kaczorowski, et al.
Journal of Bone Oncology|June 7, 2021
Differential expression of angiogenesis markers HSP70, HSP90, VEGF and pERK1/2 in both components of dedifferentiated chondrosarcomasKaren Schoedel, Virginia Miller, David Osei-Hwedieh, et al.
Oncogene|September 21, 2004
Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomaliesStefan Duensing, Anette Duensing, David C Lee, et al.
Frontiers in Oncology|May 27, 2022
Kidney Cancer Models for Pre-Clinical Drug Discovery: Challenges and OpportunitiesLaura Pohl, Jana Friedhoff, Christina Jurcic, et al.
Frontiers in Oncology|May 12, 2025
Extensive genotype-phenotype heterogeneity in renal cell carcinoma - a proof-of-concept studyJakob Wieke, Christina Jurcic, Adam Kaczorowski, et al.
Oncogene|March 10, 2004
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)Anette Duensing, Fabiola Medeiros, Bryna McConarty, et al.
The American Journal of Surgical Pathology|June 30, 2004
KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implicationsFabiola Medeiros, Christopher L Corless, Anette Duensing, et al.
Scientific Reports|August 31, 2024
Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BADAnn-Kathrin Huber, Adam Kaczorowski, Felix Schneider, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active SurveillanceViktoria Schütz, Maresa Rothermel, Adam Kaczorowski, et al.
Molecular Oncology|December 1, 2010
Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cellsDavid Reynoso, Laura K Nolden, Dan Yang, et al.
Pageof 8